In vivo monitoring of the therapeutic efficacy of a CXCR1/2 inhibitor with 18F-FDG PET/CT imaging in experimental head and neck carcinoma: A feasibility study
- DOI
- 10.1016/j.bbrep.2021.101098
- Published
- 2021-09
- Container
- Biochemistry and Biophysics Reports
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.bbrep.2021.101098,
title = {In vivo monitoring of the therapeutic efficacy of a CXCR1/2 inhibitor with 18F-FDG PET/CT imaging in experimental head and neck carcinoma: A feasibility study},
author = {Christopher Montemagno and Benjamin Serrano and Jérôme Durivault and Valérie Nataf and François Mocquot and Régis Amblard and Valérie Vial and Cyril Ronco and Rachid Benhida and Maeva Dufies and Marc Faraggi and Gilles Pagès},
year = {2021},
journal = {Biochemistry and Biophysics Reports},
doi = {10.1016/j.bbrep.2021.101098},
url = {https://doi.org/10.1016/j.bbrep.2021.101098}
}RIS
TY - JOUR TI - In vivo monitoring of the therapeutic efficacy of a CXCR1/2 inhibitor with 18F-FDG PET/CT imaging in experimental head and neck carcinoma: A feasibility study AU - Christopher Montemagno AU - Benjamin Serrano AU - Jérôme Durivault AU - Valérie Nataf AU - François Mocquot AU - Régis Amblard AU - Valérie Vial AU - Cyril Ronco AU - Rachid Benhida AU - Maeva Dufies AU - Marc Faraggi AU - Gilles Pagès PY - 2021 JO - Biochemistry and Biophysics Reports DO - 10.1016/j.bbrep.2021.101098 UR - https://doi.org/10.1016/j.bbrep.2021.101098 ER -
APA
Montemagno, C., Serrano, B., Durivault, J., Nataf, V., Mocquot, F., Amblard, R., Vial, V., Ronco, C., Benhida, R., Dufies, M., Faraggi, M., & Pagès, G. (2021). In vivo monitoring of the therapeutic efficacy of a CXCR1/2 inhibitor with 18F-FDG PET/CT imaging in experimental head and neck carcinoma: A feasibility study. Biochemistry and Biophysics Reports. https://doi.org/10.1016/j.bbrep.2021.101098
Source records
- crossref · retrieved 2026-09-26T15:15:35.471Z